Safety and Protective Effect Study of GSK Biologicals' Human Papillomavirus (Types 16, 18) Vaccine, Adsorbed (GSK580299) in Healthy Female Subjects From the HPV-039 Study

Clinical trial NCT03629886 · COMPLETED

Trial details

NCT number: NCT03629886
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Cervical Intraepithelial Neoplasia

Start date: 2018-08-22
Primary completion: 2020-02-28
Enrollment: 6051

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.